FDA NDC
PRIMAXIN IV
This name is from the loaded FDA file.
Source: FDA NDC Directory, live from openFDA. Publisher page
- NDC
- 0006-3516
- Proprietary name
- PRIMAXIN IV
- Nonproprietary name
- imipenem and cilastatin sodium
- Labeler
- Merck Sharp & Dohme LLC
- Dosage form
- INJECTION, POWDER, FOR SOLUTION
- Strength
- 500 mg/100mL
Run it in Rivvi
Which 2027 plans near you dropped or restricted imipenem and cilastatin sodium?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan, from the CMS Part D files.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.